Saturday, September 4, 2010

AIDS Quest to Kill `Sleeping' Virus Enlists Merck Cancer Drug

AIDS Quest to Kill `Sleeping' Virus Enlists Merck Cancer Drug - Bloomberg: "Researchers at the University of North Carolina in Chapel Hill plan to test Merck’s drug, Zolinza, next year in about 20 people infected with HIV, the AIDS virus. The goal is to determine if Zolinza, or a medicine like it, can force HIV out of cells where it can reside, concealed from attack by potent antiviral treatments, said David Margolis, a professor of medicine who’s leading the research."

No comments: